The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
TILAK GmbH, Cancer Registry of Tyrol, Innsbruck, Austria
University for Health Sciences, Medical Informatics and Technology, Department of Public Health and Health Technology Assessment, Hall i.T, Austria
Oncotyrol Center for Personalized Cancer Medicine, Oncotyrol Division of Public Health Decision Modelling, Health Technology Assessment and Health Economics, Innsbruck, Austria
University for Health Sciences, Medical Informatics and Technology, Department of Public Health and Health Technology Assessment, Hall i.T, Austria
Oncotyrol Center for Personalized Cancer Medicine, Oncotyrol Division of Public Health Decision Modelling, Health Technology Assessment and Health Economics, Innsbruck, Austria
Massachusetts General Hospital, Harvard Medical School, Cardiovascular Research Program, Department of Radiology, Institute for Technology Assessment, Boston, USA
Harvard School of Public Health, Center for Health Decision Science, Department of Health Policy and Management, Boston, USA